{"id":49605,"date":"2022-10-13T18:01:54","date_gmt":"2022-10-13T16:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/"},"modified":"2022-10-13T18:01:54","modified_gmt":"2022-10-13T16:01:54","slug":"the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/","title":{"rendered":"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy"},"content":{"rendered":"
\n

\nThe ONE Forum 2022 gives industry professionals practical strategies and best practices to break down barriers from diagnosis through treatment and recovery and expand access to treatment for more patients.<\/i>\n<\/p>\n

<\/a><\/p>\n

MINNEAPOLIS–(BUSINESS WIRE)–The National Marrow Donor Program\u00ae (NMDP)\/Be The Match\u00ae<\/a> announced it will host The ONE Forum 2022<\/a> as a hybrid virtual and in-person event on Nov. 4 and 5, 2022. The event brings together the global cell therapy community, highlighting the latest innovations in cellular therapy and providing a forum for health care professionals to discuss practical strategies and best practices in delivering cell therapies for patients with blood cancers and diseases.\n<\/p>\n

\nHealth care professionals worldwide are expected to attend, representing a global network of centers that help facilitate life-saving cell therapies.\n<\/p>\n

\nKeynote speakers will share their insights and personal stories on topics such as potential barriers patients face in receiving life-saving cellular therapies; strategies to build a more inclusive transplant system for all patients and expand access to treatment; and techniques for monitoring, preventing and treating disease relapse to advance patient outcomes. There will be leadership and professional development opportunities including a keynote session featuring, Alex Sheen, Founder of because I said I would<\/i>, a social movement and non-profit dedicated to bettering humanity through promises made and kept.\n<\/p>\n

\nIn addition, more than 80 industry experts<\/a> will participate and address critical topics<\/a> in the cell and gene therapy industry. Visit the event website<\/a> for a complete agenda, registration and travel information.\n<\/p>\n

\nBackground:\n<\/p>\n

\nThe National Marrow Donor Program\u00ae (NMDP)\/Be The Match\u00ae<\/a> is the leading global partner working to save lives through cellular therapy. With 35 years of experience managing the most diverse registry of potential unrelated blood stem cell donors and cord blood units in the world, NMDP\/Be The Match is a proven partner in providing cures to patients with life-threatening blood and marrow cancers and diseases. Through their global network, they connect centers and patients to their best cell therapy option\u2014from blood stem cell transplant to a next-generation therapy\u2014and collaborate with cell and gene therapy companies to support therapy development and delivery through Be The Match BioTherapies\u00ae. NMDP\/Be The Match is a tireless advocate for the cell therapy community, working with hematologists\/oncologists to remove barriers to consultation and treatment, and supporting patients through no-cost programs to eliminate non-medical obstacles to cell therapy. In addition, they are a global leader in research through the CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research\u00ae)\u2014a collaboration with the Medical College of Wisconsin, investing in and managing research studies that improve patient outcomes and advance the future of care.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nClarity Quest, (877) 887-7611
\n
Bonnie Quintanilla, bonnie@clarityqst.com<\/a>
Phyllis Grabot, phyllis@clarityqst.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The ONE Forum 2022 gives industry professionals practical strategies and best practices to break down barriers from diagnosis through treatment and recovery and expand access to treatment for more patients. MINNEAPOLIS–(BUSINESS WIRE)–The National Marrow Donor Program\u00ae (NMDP)\/Be The Match\u00ae announced it will host The ONE Forum 2022 as a hybrid virtual and in-person event on … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49605","6":"format-standard","7":"category-industry"},"yoast_head":"\nThe ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The ONE Forum 2022 gives industry professionals practical strategies and best practices to break down barriers from diagnosis through treatment and recovery and expand access to treatment for more patients. MINNEAPOLIS–(BUSINESS WIRE)–The National Marrow Donor Program\u00ae (NMDP)\/Be The Match\u00ae announced it will host The ONE Forum 2022 as a hybrid virtual and in-person event on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-13T16:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221013005810\/en\/1601531\/21\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy\",\"datePublished\":\"2022-10-13T16:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/\"},\"wordCount\":454,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005810\\\/en\\\/1601531\\\/21\\\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/\",\"name\":\"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005810\\\/en\\\/1601531\\\/21\\\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg\",\"datePublished\":\"2022-10-13T16:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005810\\\/en\\\/1601531\\\/21\\\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005810\\\/en\\\/1601531\\\/21\\\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/","og_locale":"en_US","og_type":"article","og_title":"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy - Pharma Trend","og_description":"The ONE Forum 2022 gives industry professionals practical strategies and best practices to break down barriers from diagnosis through treatment and recovery and expand access to treatment for more patients. MINNEAPOLIS–(BUSINESS WIRE)–The National Marrow Donor Program\u00ae (NMDP)\/Be The Match\u00ae announced it will host The ONE Forum 2022 as a hybrid virtual and in-person event on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-13T16:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221013005810\/en\/1601531\/21\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy","datePublished":"2022-10-13T16:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/"},"wordCount":454,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005810\/en\/1601531\/21\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/","url":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/","name":"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005810\/en\/1601531\/21\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg","datePublished":"2022-10-13T16:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221013005810\/en\/1601531\/21\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221013005810\/en\/1601531\/21\/NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-one-forum-2022-to-focus-on-the-latest-innovations-in-cellular-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The ONE Forum\u00ae 2022 To Focus On The Latest Innovations In Cellular Therapy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49605"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49605\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}